Although none of the 24 anticancer drugs IC50s was shown to be statistically correlated with NR0B1 expression in HCC, there was a tendency of positive correlation (0.05 < p < 0.1) between NR0B1 expression and the IC50s of PLX4720, Panobinostat, and Topotecan (Fig. 9N–P). This evidence concerns the gene NR0B1 and hepatocellular carcinoma.